In this edition of Pharmacy Pearls, we compare the gastrointestinal (GI) and cardiovascular (CV) risks of the most common non-selective and selective non-steroidal anti-inflammatory drugs (NSAIDs). You will also find strategies…
In this two-page edition of Pharmacy Pearls, you will find a summary of the 2022 pharmacy savings opportunities identified by the AHP Pharmacy Team. There are opportunities in several therapeutic areas…
In this edition of Pharmacy Pearls, you will find a few key updates from the 2022 American Diabetes Association Standards of Medical Care in Diabetes. Most notably, metformin (while still…
Erica Dobson, Director of Pharmacy Services at AHP, accepted a promotional opportunity within the University of Rochester Medical Center, and her last day was December 31, 2021. Erica did an…
In this edition of Pharmacy Pearls, we review the two new outpatient COVID-19 antiviral treatment options under EUA, Paxlovid™ and molnupiravir. Place in therapy, indications for use, clinical data, dosing and…
In this edition of Pharmacy Pearls, we review the use of Trelegy Ellipta for COPD, including some of the clinical trial outcomes that demonstrate benefits of triple therapy and which…
This edition of Pharmacy Pearls reviews single maintenance and reliever therapy (or SMART) for asthma management in patients >12 years old. Referenced in both GINA 2021 and NHLBI 2020 asthma…
This edition of Pharmacy Pearls addresses the alarming rise in outpatient prescribing and dispensing of ivermectin for treatment of COVID-19. There is insufficient evidence at present to support the use…
